S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Give up the OPEC fight with these 3 stocks, Buffett-certified
AI revolution: 3 stocks set to soar as technology evolves
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 reasons a squeeze could be in Paramount's coming attractions
BellRing Brands gets pumped on the Ozempic weight-loss trend
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Americans Ditched Big Cities During the Pandemic. Now Many Are Regretting It.
Teva Pharma is the way to play the re-rise of generic drugs
S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Give up the OPEC fight with these 3 stocks, Buffett-certified
AI revolution: 3 stocks set to soar as technology evolves
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 reasons a squeeze could be in Paramount's coming attractions
BellRing Brands gets pumped on the Ozempic weight-loss trend
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Americans Ditched Big Cities During the Pandemic. Now Many Are Regretting It.
Teva Pharma is the way to play the re-rise of generic drugs
S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Give up the OPEC fight with these 3 stocks, Buffett-certified
AI revolution: 3 stocks set to soar as technology evolves
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 reasons a squeeze could be in Paramount's coming attractions
BellRing Brands gets pumped on the Ozempic weight-loss trend
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Americans Ditched Big Cities During the Pandemic. Now Many Are Regretting It.
Teva Pharma is the way to play the re-rise of generic drugs
S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Give up the OPEC fight with these 3 stocks, Buffett-certified
AI revolution: 3 stocks set to soar as technology evolves
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 reasons a squeeze could be in Paramount's coming attractions
BellRing Brands gets pumped on the Ozempic weight-loss trend
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Americans Ditched Big Cities During the Pandemic. Now Many Are Regretting It.
Teva Pharma is the way to play the re-rise of generic drugs

Gorman-Rupp (GRC) Competitors

$31.76
+0.01 (+0.03%)
(As of 11/27/2023 ET)
Compare
Today's Range
$31.36
$32.03
50-Day Range
$29.51
$33.01
52-Week Range
$22.92
$33.74
Volume
30,201 shs
Average Volume
41,199 shs
Market Capitalization
$831.79 million
P/E Ratio
29.41
Dividend Yield
2.27%
Price Target
$40.00

GRC vs. TWI, HY, SCSC, IRBT, CENX, MRC, KRNT, XMTR, ASTE, and PRLB

Should you be buying Gorman-Rupp stock or one of its competitors? The main competitors of Gorman-Rupp include Titan International (TWI), Hyster-Yale Materials Handling (HY), ScanSource (SCSC), iRobot (IRBT), Century Aluminum (CENX), MRC Global (MRC), Kornit Digital (KRNT), Xometry (XMTR), Astec Industries (ASTE), and Proto Labs (PRLB). These companies are all part of the "industrial products" sector.

Gorman-Rupp vs.

Gorman-Rupp (NYSE:GRC) and Titan International (NYSE:TWI) are both small-cap industrial products companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, analyst recommendations, community ranking, earnings, dividends and profitability.

Gorman-Rupp has a beta of 0.85, meaning that its stock price is 15% less volatile than the S&P 500. Comparatively, Titan International has a beta of 2.25, meaning that its stock price is 125% more volatile than the S&P 500.

Titan International has a net margin of 6.35% compared to Gorman-Rupp's net margin of 4.40%. Titan International's return on equity of 25.27% beat Gorman-Rupp's return on equity.

Company Net Margins Return on Equity Return on Assets
Gorman-Rupp4.40% 8.83% 3.36%
Titan International 6.35%25.27%8.23%

Titan International received 30 more outperform votes than Gorman-Rupp when rated by MarketBeat users. However, 62.53% of users gave Gorman-Rupp an outperform vote while only 62.52% of users gave Titan International an outperform vote.

CompanyUnderperformOutperform
Gorman-RuppOutperform Votes
302
62.53%
Underperform Votes
181
37.47%
Titan InternationalOutperform Votes
332
62.52%
Underperform Votes
199
37.48%

Gorman-Rupp currently has a consensus price target of $40.00, suggesting a potential upside of 25.94%. Given Gorman-Rupp's higher probable upside, equities research analysts plainly believe Gorman-Rupp is more favorable than Titan International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Gorman-Rupp
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Titan International
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

In the previous week, Gorman-Rupp had 1 more articles in the media than Titan International. MarketBeat recorded 1 mentions for Gorman-Rupp and 0 mentions for Titan International. Gorman-Rupp's average media sentiment score of 1.27 beat Titan International's score of 0.00 indicating that Gorman-Rupp is being referred to more favorably in the media.

Company Overall Sentiment
Gorman-Rupp Positive
Titan International Neutral

Titan International has higher revenue and earnings than Gorman-Rupp. Titan International is trading at a lower price-to-earnings ratio than Gorman-Rupp, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Gorman-Rupp$521.03M1.60$11.19M$1.0829.41
Titan International$2.17B0.38$176.30M$1.956.85

60.3% of Gorman-Rupp shares are held by institutional investors. Comparatively, 80.4% of Titan International shares are held by institutional investors. 7.2% of Gorman-Rupp shares are held by insiders. Comparatively, 18.3% of Titan International shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Titan International beats Gorman-Rupp on 10 of the 17 factors compared between the two stocks.


Get Gorman-Rupp News Delivered to You Automatically

Sign up to receive the latest news and ratings for GRC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GRC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GRC vs. The Competition

MetricGorman-RuppPumps & pumping equipment IndustryIndustrial SectorNYSE Exchange
Market Cap$831.79M$10.58B$7.75B$15.54B
Dividend Yield2.27%1.41%2.17%3.79%
P/E Ratio29.4130.3219.8625.09
Price / Sales1.603.265.756.89
Price / Cash17.5018.3414.5815.31
Price / Book2.504.093.126.55
Net Income$11.19M$297.36M$438.76M$905.62M
7 Day Performance0.32%-0.06%-0.12%2.36%
1 Month Performance2.75%7.43%8.35%12.83%
1 Year Performance14.66%1.44%35.23%1.38%

Gorman-Rupp Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TWI
Titan International
2.0232 of 5 stars
$13.08
-3.1%
N/A-11.0%$809.52M$1.94B6.717,500
HY
Hyster-Yale Materials Handling
2.341 of 5 stars
$47.07
+1.0%
$77.50
+64.6%
+61.9%$808.95M$4.08B7.528,200
SCSC
ScanSource
2.2697 of 5 stars
$31.75
-2.8%
$35.00
+10.2%
+2.5%$792.70M$3.72B9.922,300News Coverage
IRBT
iRobot
1.9806 of 5 stars
$29.52
-3.3%
$51.00
+72.8%
-34.2%$850.47M$940.91M-2.501,254Analyst Downgrade
News Coverage
CENX
Century Aluminum
0.6445 of 5 stars
$8.06
-0.1%
$7.50
-6.9%
-7.9%$744.78M$2.20B-3.951,956
MRC
MRC Global
2.3025 of 5 stars
$10.63
-2.7%
$14.75
+38.8%
-9.4%$896.11M$3.36B10.122,800
KRNT
Kornit Digital
1.7908 of 5 stars
$17.89
-5.9%
$26.40
+47.6%
-25.4%$896.58M$226.50M-11.54934
XMTR
Xometry
1.1315 of 5 stars
$19.85
+0.6%
$23.89
+20.3%
-48.0%$899.05M$433.46M-11.75914
ASTE
Astec Industries
2.5741 of 5 stars
$31.79
-1.2%
$53.00
+66.7%
-28.1%$722.87M$1.35B40.764,291
PRLB
Proto Labs
1.7253 of 5 stars
$36.30
-0.6%
$38.33
+5.6%
+44.7%$936.18M$488.40M-9.452,568

Related Companies and Tools

This page (NYSE:GRC) was last updated on 11/28/2023 by MarketBeat.com Staff

My Account -